Physician
Borrillo, Jesus
Borrillo, Jesus was paid $925K by Medicaid between Jan 2018 and Oct 2024, across 8 billing codes. Its largest line is 67028, Intravitreal injection of a pharmacologic agent — 49% of everything it billed.
33Billing provider infoBORRILLO, JESUS
MOUNTAIN VIEW, CA 94040
MOUNTAIN VIEW, CA 94040
33aNPI1861487100assigned 09/13/2005
33bProvider typeOphthalmology Physician
28Total paid$925K
24GClaims7,802
24DCodes billed8
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Ophthalmology Physician providers in California
Rank by total paid#82 of 759
Median peer was paid$35K
This provider vs. median26×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,228 | $94K | |
| 2019 | 1,323 | $108K | |
| 2020 | 921 | $121K | |
| 2021 | 979 | $235K | |
| 2022 | 928 | $105K | |
| 2023 | 1,204 | $138K | |
| 2024incomplete | 1,219 | $125K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 67028 | Intravitreal injection of a pharmacologic agent | 49% | 1,476 | 1,309 | $449K |
| J0178 | Injection, aflibercept, 1 mg | 24% | 104 | 94 | $220K |
| 92134 | 9.2% | 2,312 | 2,183 | $85K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 7.7% | 1,660 | 1,589 | $71K |
| 92250 | 5.2% | 1,069 | 1,002 | $48K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.9% | 620 | 597 | $27K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 1.4% | 296 | 296 | $13K |
| J9035 | Injection, bevacizumab, 10 mg | 1.3% | 265 | 220 | $12K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.